Changes in mortality related to human immunodeficiency virus infection: Comparative analysis of inpatient deaths in 1995 and in 1999-2000

Clinical Infectious Diseases

Volumn 36, Issue 8, 2003, Pages 1030-1038

  Jain, Mamta K ^a   Skiest, Daniel J ^a   Cloud, Jeff W ^b   Jain, Charu L ^b   Burns, Dennis ^b   Berggren, Ruth E ^c,d  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c TULANE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^d TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGED; ARTICLE; CAUSE OF DEATH; COMPARATIVE STUDY; DEATH; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITAL PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; OPPORTUNISTIC INFECTION; PATIENT COMPLIANCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; MIDDLE AGED; SURVIVAL;

ADULT; AGED; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; MORTALITY; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 0037445552     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/368186     Document Type: Article

References (24)

1. Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998; 338:853-60.
2. Brodt HR, Kamps BS, Gute P, Knupp B, Staszewski S, Helm EB. Changing incidence of AIDS-defning illnesses in the era of antiretroviral combination therapy. AIDS 1997; 11:1731-8.
3. McNaghten AD, Hanson DL, Jones JL, Dworkin MS, Ward JW. Effects of antiretrovirai therapy and opportunistic illness primary chemoprophylaxis on survival after AIDS diagnosis. Adult/Adolescent Spectrum of Disease Group. AIDS 1999; 13:1687-95.
4. Hogg RS, O'shaughnessy MV, Gataric N, et al. Decline in deaths from AIDS due to new antiretrovirals. Lancet 1997; 349:1294.
5. Chiasson MA, Berenson L, Li W, et al. Declining HIV/AIDS mortality in New York City. J Acquir Immune Defic Syndr 1999; 21:59-64.
6. Valdez H, Chowdhry TK, Asaad R, et al. Changing spectrum of mortality due to human immunodeficiency virus: analysis of 260 deaths during 1995-1999. Clin Infect Dis 2001; 32:1487-93.
7. Lewden CH, Héripret L, Bonnet L, et al. Causes of death in HIV-infected adults in the era of highly active antiretroviral therapy (HAART): the French Survey "Mortalite 2000" [abstract 753-W]. In: Programs and abstracts of the 9th Conference on Retroviruses and Opportunistic Infections (Seattle). Alexandria, VA: Foundation for Retrovirology and Human Health, 2002:326.
8. Morgello S, Mahboob R, Yakoushina T, Khan S, Hague K. Autopsy findings in a human immunodeficiency virus-infected population over 2 decades: influences of gender, ethnicity, risk factors, and time. Arch Pathol Lab Med 2002; 126:182-90.
9. Sansone GR, Frengley JD. Impact of HAART on causes of death of persons with late-stage AIDS. J Urban Health 2000; 77:166-75.
10. Wolfe MI, Hanson DL, Selik DL, Swerdlow R. Deaths from non-AIDS-related diseases have increased as a proportion of deaths of HIV-infected persons since the advent of HAART [abstract 14]. In: Programs and abstracts of the 9th Conference on Retroviruses and Opportunistic Infections (Seattle). Alexandria, VA: Foundation for Retrovirology and Human Health, 2002:57.
11. Jambroes MD, Dieleman J, van de Wiel J, et al. Changing mortality in an HIV-infected population on HAART [abstract 754-W]. In: Programs and abstracts of the 9th Conference on Retroviruses and Opportunistic Infections (Seattle). Alexandria, VA: Foundation for Retrovirology and Human Health, 2002:326.
12. Folch EH, Herández I, Vetter T, et al. AIDS-related mortality: improved survival with HAART but causes of death unchanged [abstract 756-W]. In: Programs and abstracts of the 9th Conference on Retroviruses and Opportunistic Infections (Seattle). Alexandria, VA: Foundation for Retrovirology and Human Health, 2002:327.
13. Rodríguez BV, Valdez H, Salata H, et al. Changes in causes of death in a cohort of HIV-infected individuals: analysis of the last 6 years [abstract 755-W]. In: Programs and abstracts of the 9th Conference on Retroviruses and Opportunistic Infections (Seattle). Alexandria, VA: Foundation for Retrovirology and Human Health, 2002:327.
14. Cacoub P, Geffray L, Rosenthal E, Perronne C, Veyssier P, Raguin G. Mortality among human immunodeficiency virus-infected patients with cirrhosis or hepatocellular carcinoma due to hepatitis C virus in French Departments of Internal Medicine/Infectious Diseases, in 1995 and 1997. Clin Infect Dis 2001; 32:1207-14.
15. Bica I, McGovern B, Dhar R, et al. Increasing mortality due to endstage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis 2001; 32:492-7.
16. Centers for Disease Control and Prevention. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 1992; 41:1-19.
17. Chan IS, Neaton JD, Saravolatz LD, Crane LR, Osterberger J. Frequencies of opportunistic diseases prior to death among HIV-infected persons: community programs for clinical research on AIDS. AIDS 1995; 9:1145-51.
18. Hofman P, Saint-Paul MC, Battaglione V, Michiels JF, Loubiere R. Autopsy findings in the acquired immunodeficiency syndrome (AIDS): a report of 395 cases from the south of France. Pathol Res Pract 1999; 195:209-17.
19. Masliah E, DeTeresa RM, Mallory ME, Hansen LA. Changes in pathological findings at autopsy in AIDS cases for the last 15 years. AIDS 2000; 14:69-74.
20. Selik RM, Karon JM, Ward JW. Effect of the human immunodeficiency virus epidemic on mortality from opportunistic infections in the United States in 1993. J Infect Dis 1997; 176:632-6.
21. Hogg RS, Yip B, Chan KJ, et al. Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy. JAMA 2001; 286:2568-77.
22. Egger M, Hirschel B, Francioli P, et al. Impact of new antiretroviral combination therapies in HIV infected patients in Switzerland: prospective multicentre study. Swiss HIV Cohort Study. BMJ 1997; 315:1194-9.
23. Centers for Disease Control and Prevention. US HIV and AIDS cases reported through December 2000. AIDS Surveill Rep 2001; 12:28.
24. Rapiti E, Porta D, Forastiere F, Fusco D, Perucci CA. Socioeconomic status and survival of persons with AIDS before and after the introduction of highly active antiretroviral therapy. Lazio AIDS Surveillance Collaborative Group. Epidemiology 2000; 11:496-501.